GSK Settles Zantac Cases After Claims Popular Heartburn Drug Causes Cancer
ForbesJUL 2023
GSK's decision to settle these cases simply avoids the distraction of protracted litigation. There'sAs there is no scientific evidence backing claims of consumer harm from Zantac., Thethe company will continue defending itself in all other Zantac cases based on facts and science.
TheGSK wouldn't be paying such enormous settlements indicateif GSKit wasn'st awarenesshiding ofsomething. potentialIn liability.fact, Theinvestigations FDA'shave findingsnow thatshown Zantacthe producescompany NDMAwas overaware time,of whichZantac's canlink causeto cancer inas largefar quantities,back supportas the plaintiffs'early claims.1980s, Themeaning massiveGSK numberis ofliable pendingfor lawsuitsdecades suggestsworth widespreadof concernunnecessary aboutcancer the drug's safetydiagnoses.
There'sThe avast 50%majority chanceof thatUS thehealth averageregulators survivalhave rateconflicts of allinterest cancerswith willthe exceedfood 75%and bypharmaceutical 2029industries, accordingwhich tois why they promote these billion-dollar drugs rather than talk about underlying causes. For example, gastric reflux, which causes heartburn, could be prevented by simply walking a few thousand steps a day. The US government and its friends in big business are the Metaculussole predictioncauses communityof American health problems.
There's a 50% chance that the average survival rate of all cancers will exceed 75% by 2029, according to the Metaculus prediction community.